WuXi Biologics (Cayman) Inc. (HKG:2269)
Hong Kong · Delayed Price · Currency is HKD 47.50
-1.34 (-2.74%)
Sep 10, 2026, 4:08 PM HKT
WuXi Biologics Market Cap
WuXi Biologics has a market cap or net worth of 194.93 billion as of September 10, 2026. Its market cap has increased by 27.37% in one year.
Market Cap
194.93B
Enterprise Value
190.48B
Revenue
27.27B
Ranking
n/a
PE Ratio
34.74
Stock Price
47.50
ChartMarket Cap Chart
Since June 13, 2017, WuXi Biologics's market cap has increased from 32.04B to 194.93B, an increase of 508.41%. That is a compound annual growth rate of 21.56%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 10, 2026 | 194.93B | 49.99% |
| Dec 31, 2025 | 129.96B | 80.25% |
| Dec 31, 2024 | 72.10B | -42.32% |
| Dec 29, 2023 | 124.99B | -50.53% |
| Dec 30, 2022 | 252.68B | -35.37% |
| Dec 31, 2021 | 390.94B | -6.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 13, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 319.41B |
| Innovent Biologics | 176.36B |
| Sichuan Kelun-Biotech Biopharmaceutical | 117.22B |
| Sino Biopharmaceutical | 97.42B |
| Akeso | 88.43B |
| Genscript Biotech | 67.79B |
| RemeGen | 67.07B |
| Biocytogen Pharmaceuticals (Beijing) | 53.26B |